Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study)

First-line triplet chemotherapy including a taxane may prolong survival in patients with metastatic esophagogastric cancer. The added toxicity of the taxane might be minimized by using nab-paclitaxel. The aim of this phase I study was to determine the feasibility of combining nab-paclitaxel with the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Schokker, Sandor, van der Woude, Stephanie O., van Kleef, Jessy Joy, van Zoen, Daan J., van Oijen, Martijn G. H., Mearadji, Banafsche, Beenen, Ludo F. M., Stroes, Charlotte I., Waasdorp, Cynthia, Jibodh, R. Aarti, Creemers, Aafke, Meijer, Sybren L., Hooijer, Gerrit K. J., Punt, Cornelis J. A., Bijlsma, Maarten F., van Laarhoven, Hanneke W. M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6627561/
https://ncbi.nlm.nih.gov/pubmed/31207904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11060827
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak